| Serial Number | 97276914 |
| Word Mark | ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS |
| Filing Date | Monday, February 21, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Tuesday, August 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 10, 2023 |
| Description of Mark | The mark consists of a purple circle icon with three intersecting curved white lines. The intersecting white lines comprise five sections of the circle in various sizes where the curve of the circle forms the outer edge of each shape; the top left of the circle is a gradient purple shape, the top right is a purple shape, the middle is a green triangular shape, the bottom left is a small purple triangular shape, and the bottom right is a gradient purple and orange shape. Below the circle icon is the word ARCHIMMUNE where the letters ARCH are gray capital letters in light font and the letters IMMUNE are purple capital letters in heavy font, all of which is above the words ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS in gray capitalized text. Areas in white not claimed herein are for background only and are not claimed as part of the mark. |
| Indication of Colors claimed | The color(s) purple, green, orange, gray and white is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "SOLUTIONS" |
| Goods and Services | Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 24, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Archimmune Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Party Name | Archimmune Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Event Date | Event Description |
| Thursday, February 24, 2022 | NEW APPLICATION ENTERED |
| Thursday, February 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 25, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, December 5, 2022 | ASSIGNED TO EXAMINER |
| Monday, December 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 21, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 10, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 10, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, September 7, 2023 | SOU EXTENSION 1 FILED |
| Monday, October 9, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, October 10, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, October 10, 2023 | TEAS PETITION TO REVIVE RECEIVED |
| Tuesday, October 10, 2023 | PETITION TO REVIVE-GRANTED |
| Tuesday, October 10, 2023 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, October 10, 2023 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Tuesday, October 10, 2023 | NOTICE OF REVIVAL - E-MAILED |
| Monday, October 23, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, October 26, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, October 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, February 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 5, 2024 | SOU EXTENSION 2 FILED |
| Monday, February 5, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, February 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 27, 2024 | SOU EXTENSION 3 GRANTED |
| Tuesday, August 27, 2024 | SOU EXTENSION 3 FILED |